Intelligent Bio Solutions (NASDAQ: INBS) — Perfil da empresa, notícias e dados financeiros
Intelligent Bio Solutions develops biotechnology solutions addressing challenges in health, agriculture, and environment sectors.
Intelligent Bio Solutions
Intelligent Bio Solutions (NASDAQ:INBS) focuses on developing innovative solutions in the biosciences realm. The company's operations span across a variety of projects with objectives concentrated on harnessing biotechnology to address complex challenges in health, agriculture, and environment sectors. Despite the diversity of their portfolio, all projects are united by a common goal: to leverage scientific advancements for tangible, beneficial impacts in their target markets. While Intelligent Bio Solutions is currently traded exclusively on the NASDAQ under the ticker symbol INBS, its broad scope of activities and commitment to cutting-edge bioscience research underpin its vision to improve lives and foster sustainable practices globally.
Resumo
Operações
Produtos e/ou serviços de Intelligent Bio Solutions
- Development of innovative diagnostic tools aimed at enhancing rapid testing capabilities for infectious diseases, including COVID-19, to offer precise and swift results.
- Production of advanced PCR (Polymerase Chain Reaction) testing kits which provide highly accurate detection of various pathogens, thus facilitating effective disease management and control.
- Offering cutting-edge bioinformatics services that utilize data analytics and computational biology to support research in genomics, proteomics, and disease pathology.
- Manufacturing of high-quality molecular diagnostics products that support laboratory operations in clinical diagnostics, including reagents and instruments critical for accurate testing.
- Creation of a robust telemedicine platform that integrates health monitoring and diagnostic services, enabling remote healthcare delivery and patient management.
- Providing comprehensive laboratory services ranging from routine blood tests to complex genetic testing, assisting healthcare providers in making informed treatment decisions.
equipe executiva do Intelligent Bio Solutions
- Harry SimeonidisPresident & CEO
- Spiro Kevin SakirisChief Financial Officer
- Callistus SequeiraVice President of Global Quality & Operations
- Doug HeathVice President of Global Sales
- Anna TurkingtonVice President of Marketing
- Valter PintoManaging Director of KCSA Strategic Communications
- Peter PassarisVice President of Product Development
Últimas notícias sobre a Intelligent Bio Solutions
Principais indicadores financeiros
Resultados divulgados pela Intelligent Bio Solutions, em USD.
- Cap. de mercado
- 5,7 mi
- Receita (TTM)
- 4,2 mi
- P/L
- —
- LPA (diluído, TTM)
- -8.4
- Dividend yield
- —
- Margem de lucro
- -294.9%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 4,2 mi | -12,6 mi | -12,4 mi | |
| 3,1 mi | -10,6 mi | -10,6 mi | |
| 3,1 mi | -10,3 mi | -10,2 mi | |
| 1,3 mi | -12,6 mi | -10,6 mi |